论文部分内容阅读
恶性肿瘤是当前人类死亡的主要原因之一,而机体免疫功能的降低又为治疗肿瘤带来困难。近年来用免疫疗法调动增强机体自身的自然抗肿瘤免疫力,是继肿瘤的手术、放射和化学治疗的一种有效治疗手段。 现已公认,细胞免疫在机体抗肿瘤中起着重要作用,而传统概念认为红细胞(Red Blood Cell,RBC)只有呼吸功能,Siegel 1981年提出“红细胞免疫系统”的概念,认为RBC是免疫系统必需的成分之一。1982年,国内首次建立了RBCC_3b受体花环试验及RBC免疫复合物花环试验等,RBC
Malignant tumors are one of the major causes of human death. However, the decline in immune function of the body has also made it difficult to treat tumors. In recent years, the use of immunotherapy to mobilize and enhance the body’s own natural anti-tumor immunity is an effective treatment for tumors following surgery, radiation, and chemotherapy. It is now recognized that cellular immunity plays an important role in the body’s anti-tumor, and the traditional concept is that the Red Blood Cell (RBC) only has respiratory function. Siegel proposed the concept of “red blood cell immune system” in 1981, and believes that RBC is necessary for the immune system. One of the ingredients. In 1982, the first domestic RBCC_3b receptor rosette test and RBC immune complex rosette trial, RBC